Calendar Theravance Biopharma, Inc.

Equities

TBPH

KYG8807B1068

Market Closed - Nasdaq 04:00:00 2024-04-12 pm EDT 5-day change 1st Jan Change
9.61 USD +7.61% Intraday chart for Theravance Biopharma, Inc. +3.22% -14.50%

Chart calendar Theravance Biopharma, Inc.

c3.IZOEbFHhrdxCi9Ev13-V1VEyhR_E3ZHqFw_bj7PYD_o.QqT0PAeu94t7_JAcmDS4pCNTzVmxsLzSYkCLwOm6XZ5s8cxdJ5CArATunA~91d2bc8de63851877b5a0a707ff18cf1

Upcoming events on Theravance Biopharma, Inc.

2024-04-18 12:00 pm Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
2024-05-06 Q1 2024 Earnings Release (Projected)
2024-05-07 Annual General Meeting
2024-05-23 10:00 am Investor Meeting - Key Openion Leader
2024-07-30 Q2 2024 Earnings Release (Projected)
2024-11-04 Q3 2024 Earnings Release (Projected)
2025-03-02 Q4 2024 Earnings Release (Projected)

Past events on Theravance Biopharma, Inc.

2024-03-05 10:30 am TD Cowen Health Care Conference
2024-02-26 05:00 pm Q4 2023 Earnings Call
2024-02-26 04:05 pm Q4 2023 Earnings Release
2024-01-07 JPMorgan Healthcare Conference
2023-11-28 01:45 pm Evercore ISI HealthCONx Conference
2023-11-16 06:00 pm American Autonomic Society Autonomic Nervous System International Symposium - Poster #95
2023-11-07 05:00 pm Q3 2023 Earnings Call
2023-11-07 04:28 pm Q3 2023 Earnings Release
2023-09-12 09:30 am H.C. Wainwright Global Investment Conference
2023-08-28 07:00 am Parkinson Disease and Movement Disorders International Congress - Abstract No : 7
2023-08-28 07:00 am Parkinson Disease and Movement Disorders International Congress - Abstract No : 3
2023-08-07 05:00 pm Q2 2023 Earnings Call
2023-08-07 04:05 pm Q2 2023 Earnings Release
2023-05-08 05:00 pm Q1 2023 Earnings Call
2023-05-08 04:05 pm Q1 2023 Earnings Release
2023-05-02 07:00 am Annual General Meeting
2023-04-17 03:45 pm Needham Healthcare Conference
2023-03-08 10:30 am Cowen Health Care Conference
2023-02-27 05:00 pm Q4 2022 Earnings Call
2023-02-27 04:05 pm Q4 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
73,4
61,1
20.15%
71,9
73,9
-2.71%
55,3
53,7
3.02%
51,3
51,8
-0.91%
57,4
57,5
-0.06%

70,7

EBITDA
Million USD
Released
Forecast
Spread
-249
-242
-2.7%
-289
-254
-13.47%
-190
-193
1.54%
-48,5
-51,2
5.35%
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-252
-246
-2.43%
-298
-289
-3.18%
-258
-232
-11.23%
-92,0
-88,9
-3.47%
-56,0
-59,4
5.69%

-29,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-242
-242
0.07%
-287
-282
-1.5%
-200
-186
-7.06%
-92,8
-58,9
-57.63%
-49,3
-54,4
9.35%

-23,9

Net income
Million USD
Released
Forecast
Spread
-236
-236
0%
-278
-282
1.42%
-199
-186
-6.98%
872
-60,1
1551.05%
-55,2
-53,9
-2.44%

-33,0

EPS
USD
Released
Forecast
Spread
-4,25
-4,12
-3.16%
-4,46
-4,51
1.18%
-2,87
-2,63
-9.31%
11,9
-0,83
1527.71%
-1,00
-0,97
-2.74%

-0,68

Announcement Date24/02/2023/02/2123/02/2227/02/2326/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
14,9
13,6
10.22%
13,2
14,5
-8.89%
11,1
11,8
-6.38%
12,5
11,8
5.43%
14,6
15,7
-6.86%
10,4
13,7
-23.98%
13,7
15,4
-10.84%
15,7
15,1
4.26%
17,6
17,6
-0.06%

14,0


16,1


17,1


23,6




EBITDA
Million USD
Released
Forecast
Spread
-37,9
-10,5
-261.48%







































EBIT
Million USD
Released
Forecast
Spread
-56,2
-39,2
-43.18%
-38,5
-24,8
-54.97%
-26,9
-9,94
-170.44%
-14,2
-14,9
4.8%
-17,4
-13,2
-32.18%
-24,9
-19,2
-29.99%
-16,1
-15,1
-6.65%
-8,76
-11,9
26.38%
-6,24
-9,62
35.12%

-10,4


-9,75


-8,80


-0,46




Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-32,2
-23,2
-38.69%
-25,4
-7,68
-231.05%
-8,20
20,4
-140.25%
-16,0
-0,74
-2053.63%
-14,3
-12,7
-12.38%
-22,5
-19,5
-15.01%
-14,2
-15,5
8.49%
-7,58
-12,2
37.87%
-5,02
-10,1
50.21%

-8,94


-9,47


-8,74


3,21




Net income
Million USD
Released
Forecast
Spread
-32,0
-22,9
-39.98%
-25,9
-6,59
-293.92%
-8,19
20,4
-140.22%
917
-16,4
5706.31%
-10,4
-11,0
5.78%
-22,1
-18,6
-18.45%
-15,6
-12,5
-25.14%
-8,95
-11,1
19.15%
-8,51
-7,45
-14.22%

-12,5


-10,5


-8,61


-1,43


-14,6

EPS
USD
Released
Forecast
Spread
-0,43
-0,31
-40.07%
-0,34
-0,11
-217.43%
-0,11
0,09
-226.92%
12,1
-0,22
5618.18%
-0,15
-0,17
13.04%
-0,35
-0,25
-41.89%
-0,28
-0,21
-33.33%
-0,17
-0,21
19.05%
-0,17
-0,15
-15.91%

-0,25


-0,21


-0,17


-0,03


-0,30

Announcement Date23/02/2205/05/2208/08/2207/11/2227/02/2308/05/2307/08/2307/11/2326/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. TBPH Stock
  4. Calendar Theravance Biopharma, Inc.